Wells Fargo cuts Ultragenyx Pharma PT to $18 from $50
Wells Fargo lowered its price target on Ultragenyx Pharma to $18.00 per share from $50.00, according to ratings actions reported by Benzinga (via TradingView News).
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.